FUDA, Giuseppe
 Distribuzione geografica
Continente #
NA - Nord America 2.074
EU - Europa 1.325
AS - Asia 695
SA - Sud America 15
AF - Africa 13
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 3
Totale 4.134
Nazione #
US - Stati Uniti d'America 2.009
IT - Italia 403
CN - Cina 316
DE - Germania 217
SG - Singapore 182
IE - Irlanda 142
SE - Svezia 111
FR - Francia 105
FI - Finlandia 82
GB - Regno Unito 71
CA - Canada 59
UA - Ucraina 50
AT - Austria 45
VN - Vietnam 38
JP - Giappone 36
IN - India 31
PL - Polonia 31
KR - Corea 29
ID - Indonesia 17
BE - Belgio 14
HK - Hong Kong 13
NL - Olanda 10
UZ - Uzbekistan 10
BR - Brasile 9
CH - Svizzera 8
AU - Australia 6
SN - Senegal 6
TW - Taiwan 6
GR - Grecia 5
MX - Messico 5
TN - Tunisia 5
CL - Cile 4
ES - Italia 4
RO - Romania 4
RU - Federazione Russa 4
EU - Europa 3
IR - Iran 3
NO - Norvegia 3
NZ - Nuova Zelanda 3
PH - Filippine 3
RS - Serbia 3
TR - Turchia 3
BG - Bulgaria 2
CZ - Repubblica Ceca 2
HU - Ungheria 2
IL - Israele 2
KZ - Kazakistan 2
LU - Lussemburgo 2
MY - Malesia 2
PT - Portogallo 2
SI - Slovenia 2
AE - Emirati Arabi Uniti 1
AR - Argentina 1
CO - Colombia 1
EG - Egitto 1
HN - Honduras 1
KE - Kenya 1
MK - Macedonia 1
TH - Thailandia 1
Totale 4.134
Città #
Chandler 244
Singapore 153
Beijing 143
Dublin 142
Santa Clara 141
Torino 130
Fairfield 125
Ashburn 116
Houston 97
Ann Arbor 78
Woodbridge 63
Wilmington 54
Villeurbanne 51
Seattle 48
Turin 48
Vienna 44
Nyköping 40
Redwood City 40
Jacksonville 39
Cambridge 38
Columbus 37
Fremont 35
Toronto 34
Medford 32
Pisa 32
Princeton 32
Warsaw 26
Dearborn 24
Dong Ket 24
Guangzhou 19
Helsinki 19
New York 17
Milan 16
Jakarta 15
Lappeenranta 15
Nürnberg 14
Brussels 13
London 13
Boston 12
Tokyo 12
Waterloo 12
Rome 11
Bochum 10
Paris 10
San Diego 10
Norwalk 8
Phoenix 8
Bologna 7
Chicago 7
Bengaluru 6
Boardman 6
Chengdu 6
Hangzhou 6
Hefei 6
Hong Kong 6
Los Angeles 6
Munich 6
San Mauro Torinese 6
Washington 6
Amsterdam 5
Hebei 5
Mumbai 5
Nanjing 5
Northampton 5
Taipei 5
Wuhan 5
Brookline 4
Jinan 4
Kunming 4
Mountain View 4
Nanchang 4
Seoul 4
Silver Spring 4
Zhengzhou 4
Atlanta 3
Baltimore 3
Basel 3
Berlin 3
Bucharest 3
Cedar Crest 3
Changchun 3
Changsha 3
Chongqing 3
Cleveland 3
Frankfurt am Main 3
Guiyang 3
Krakow 3
Kyoto 3
Modena 3
Montgomery 3
North Wales 3
Nottingham 3
Oxford 3
Padova 3
Shanghai 3
Shenyang 3
Sudbury 3
Sydney 3
Titkov 3
Villeneuve-la-garenne 3
Totale 2.563
Nome #
A20 in Multiple Sclerosis and Parkinson’s Disease: Clue to a Common Dysregulation of Anti-Inflammatory Pathways? 522
NADPH oxidase 2 (NOX2) enzyme activation in patients with chronic inflammatory demyelinating polyneuropathy 331
Decreased Levels of Foldase and Chaperone Proteins Are Associated with an Early-Onset Amyotrophic Lateral Sclerosis 292
ATXN2 is a modifier of phenotype in ALS patients of Sardinian ancestry 239
CHCH10 mutations in an Italian cohort of familial and sporadic amyotrophic lateral sclerosis patients 188
ATNX2 is not a regulatory gene in Italian amyotrophic lateral sclerosis patients with C9ORF72 GGGGCC expansion 160
NOX2 in the hSOD1G93A Transgenic Swine: a preliminary overview 158
Erythropoietin in amyotrophic lateral sclerosis: A multicentre, randomised, double blind, placebo controlled, phase III study 149
Persistent idiopathic hypoglossal nerve palsy: A motor neuron disease-mimic syndrome? 124
G-CSF (filgrastim) treatment for amyotrophic lateral sclerosis: Protocol for a phase II randomised, double-blind, placebo-controlled, parallel group, multicentre clinical study (STEMALS-II trial) 116
Genetic counselling in ALS: facts, uncertainties and clinical suggestions 116
HFE p.H63D polymorphism does not influence ALS phenotype and survival 106
NADPH oxidase (NOX2) activity is a modifier of survival in ALS 101
ALS clinical trials: Do enrolled patients accurately represent the ALS population? 101
The transcription factor Nurr1 is up-regulated in Amyotrophic Lateral Sclerosis patients and SOD1-G93A mice 97
NADPH oxidases (NOX) enzymes induced oxidative stress in CIDP patients 96
NADPH oxidase (NOX2) activity is a modifier of survival in ALS. 96
Role of NOX2 enzyme activity in neuroinflammation: preliminary results in Amyotrophic Lateral Sclerosis and Parkinson’s disease 94
ALS Clinical Trials: Do the Enrolled Patients Represent the ALS Population? 92
NADPH oxidases 2 activation in patients with Parkinson's disease 88
Role of NOX2 enzyme activity in neuroinflammation: preliminary results in Amyotrophic Lateral Sclerosis and Parkinson’s disease 87
Crostacei Decapodi dell'infralitorale della Calabria jonica 76
Association of Variants in the SPTLC1 Gene with Juvenile Amyotrophic Lateral Sclerosis 72
Amyotrophic lateral sclerosis caregiver burden and patients’ quality of life during COVID-19 pandemic 70
UNC13A influences survival in Italian amyotrophic lateral sclerosis patients: a population-based study 66
Effects of intracellular calcium accumulation on proteins encoded by the major genes underlying amyotrophic lateral sclerosis 65
Telemedicine for patients with amyotrophic lateral sclerosis during COVID-19 pandemic: an Italian ALS referral center experience 64
Tailoring patients’ enrollment in ALS clinical trials: the effect of disease duration and vital capacity cutoffs 60
Validation of the Italian version of the Rasch-Built Overall Amyotrophic Lateral Sclerosis Disability Scale (ROADS) administered to patients and their caregivers 60
A novel splice site FUS mutation in a familial ALS case: effects on protein expression 59
Identifying and predicting amyotrophic lateral sclerosis clinical subgroups: a population-based machine-learning study 47
Presymptomatic geographical distribution of ALS patients suggests the involvement of environmental factors in the disease pathogenesis 43
Brain 18fluorodeoxyglucose-positron emission tomography changes in amyotrophic lateral sclerosis with TARDBP mutations 36
Giving Breath to Motor Neurons: Noninvasive Mechanical Ventilation Slows Disease Progression in Amyotrophic Lateral Sclerosis 31
Phenotype Analysis of Fused in Sarcoma Mutations in Amyotrophic Lateral Sclerosis 29
The role of peripheral immunity in ALS: a population-based study 26
Tauroursodeoxycholic acid in patients with amyotrophic lateral sclerosis: The TUDCA-ALS trial protocol 25
Disentangling the relationship between social cognition, executive functions and behaviour changes in amyotrophic lateral sclerosis 20
Shared and Unique Disease Pathways in Amyotrophic Lateral Sclerosis and Parkinson's Disease Unveiled in Peripheral Blood Mononuclear Cells 19
Sex Differences in Amyotrophic Lateral Sclerosis Survival and Progression: A Multidimensional Analysis 15
Totale 4.236
Categoria #
all - tutte 13.307
article - articoli 0
book - libri 0
conference - conferenze 1.723
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.030


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020343 0 0 0 0 0 75 51 34 70 59 25 29
2020/2021399 23 41 23 15 42 39 20 34 51 34 19 58
2021/2022490 14 10 35 63 15 35 32 30 14 51 121 70
2022/2023726 85 65 21 62 73 170 47 30 104 13 30 26
2023/2024412 56 71 28 20 24 38 37 35 3 30 31 39
2024/2025535 17 77 46 93 237 65 0 0 0 0 0 0
Totale 4.236